Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;38:90-94

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sasaki, S.
Right arrow Articles by Oshima, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sasaki, S.
Right arrow Articles by Oshima, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Blood Pressure Medicines
*High Blood Pressure
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow Peripheral vascular disease
Right arrow Clinical Studies
Right arrow Other diagnostic testing

(Hypertension. 2001;38:90.)
© 2001 American Heart Association, Inc.


Scientific Contributions

Effects of Angiotensin-(1-7) on Forearm Circulation in Normotensive Subjects and Patients With Essential Hypertension

Shota Sasaki; Yukihito Higashi; Keigo Nakagawa; Hideo Matsuura; Goro Kajiyama; Tetsuya Oshima

From the First Department of Internal Medicine (S.S., Y.H., K.N., H.M., G.K.) and the Department of Clinical Laboratory Medicine (T.O.), Hiroshima University School of Medicine, Japan.

Correspondence to Shota Sasaki, MD, Hiroshima University School of Medicine, First Department of Internal Medicine, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan. E-mail sshota{at}mcai.med.hiroshima-u.ac.jp

Abstract— Previous animal studies have shown that angiotensin (Ang)-(1-7) is a biologically active component of the renin-angiotensin system, acting as a vasoactive agent, and may play a role in the blood pressure regulation. There is little information, however, on the effect of Ang-(1-7) on human circulation or the mechanism of its action. To investigate the effect of Ang-(1-7) on forearm circulation and to determine whether this effect is altered in patients with essential hypertension, we measured change in forearm blood flow using venous occlusion plethysmography in response to intra-arterial infusion of Ang-(1-7) (10-10, 10-9, and 10-8 mol/min; for 5 minutes) in normotensive control subjects (n=8) and patients with essential hypertension (n=8). Infusion of Ang-(1-7) significantly increased the forearm blood flow response in a dose-dependent manner in both normotensive control subjects (28.7±9.7%, at 10-8 mol/min; P<0.05) and hypertensive patients (31.8±15.2%, at 10-8 mol/min; P<0.05). The vasodilatory effect of Ang-(1-7) was similar in the two groups. Intra-arterial infusion of NG-monomethyl-L-arginine, a nitric oxide synthesis inhibitor, did not alter the forearm blood flow response to Ang-(1-7) in either group. These findings suggest that Ang-(1-7) causes vasodilation in forearm circulation of normotensive subjects and patients with essential hypertension through a pathway that is independent of nitric oxide synthesis.


Key Words: angiotensin-(1-7) • forearm blood flow • nitric oxide • hypertension, essential




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
C. Clapp, S. Thebault, M. C. Jeziorski, and G. Martinez De La Escalera
Peptide Hormone Regulation of Angiogenesis
Physiol Rev, October 1, 2009; 89(4): 1177 - 1215.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation
Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. L. Grobe, A. P. Mecca, H. Mao, and M. J. Katovich
Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2417 - H2423.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. O. Sampaio, A. A. S. Nascimento, and R. A. S. Santos
Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Systemic and regional hemodynamic effects of angiotensin-(1-7) in rats
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1985 - H1994.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. Wiemer, L. W. Dobrucki, F. R. Louka, T. Malinski, and H. Heitsch
AVE 0991, a Nonpeptide Mimic of the Effects of Angiotensin-(1-7) on the Endothelium
Hypertension, December 1, 2002; 40(6): 847 - 852.
[Abstract] [Full Text] [PDF]